Search by Drug Name or NDC

NDC 68093-7242-01 MG217 Psoriasis Therapeutic Conditioner 0.03 g/g Details

MG217 Psoriasis Therapeutic Conditioner 0.03 g/g

MG217 Psoriasis Therapeutic Conditioner is a TOPICAL SHAMPOO in the HUMAN OTC DRUG category. It is labeled and distributed by Wisconsin Pharmacal Company. The primary component is SALICYLIC ACID.

MedlinePlus Drug Summary

Topical salicylic acid is used to help clear and prevent pimples and skin blemishes in people who have acne. Topical salicylic acid is also used to treat skin conditions that involve scaling or overgrowth of skin cells such as psoriasis (a skin disease in which red, scaly patches form on some areas of the body), ichthyoses (inborn conditions that cause skin dryness and scaling), dandruff, corns, calluses, and warts on the hands or feet. Topical salicylic acid should not be used to treat genital warts, warts on the face, warts with hair growing from them, warts in the nose or mouth, moles, or birthmarks. Salicylic acid is in a class of medications called keratolytic agents. Topical salicylic acid treats acne by reducing swelling and redness and unplugging blocked skin pores to allow pimples to shrink. It treats other skin conditions by softening and loosening dry, scaly, or thickened skin so that it falls off or can be removed easily.

Related Packages: 68093-7242-01
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Salicylic Acid Topical

Product Information

NDC	68093-7242
Product ID	68093-7242_2e961928-db05-3cfd-e054-00144ff88e88
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	MG217 Psoriasis Therapeutic Conditioner
Proprietary Name Suffix	n/a
Non-Proprietary Name	Salicylic Acid
Product Type	HUMAN OTC DRUG
Dosage Form	SHAMPOO
Route	TOPICAL
Active Ingredient Strength	0.03
Active Ingredient Units	g/g
Substance Name	SALICYLIC ACID
Labeler Name	Wisconsin Pharmacal Company
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	OTC MONOGRAPH FINAL
Application Number	part333D
Listing Certified Through	2024-12-31

Package

Package Images

NDC 68093-7242-01 (68093724201)

Pricing Information	N/A
NDC Package Code	68093-7242-1
Billing NDC	68093724201
Package	1 BOTTLE in 1 CARTON (68093-7242-1) / 283 g in 1 BOTTLE
Marketing Start Date	2015-11-01
NDC Exclude Flag	N

Standard Product Labeling (SPL)/Prescribing Information SPL 246f239f-16fb-24b2-e054-00144ff8d46c Details

Active Ingredient

Salicylic Acid 3%

Purpose

Psoriasis, Seborrheic Dermatitis, Dandruff Treatment

Uses

For the temporary relief of these symptoms associate with psoriasis, seborrheic dermatitis or dandruff

itching
scaling
flaking,
reness
irritaion of the scalp

Helps prevent recurrence.

Warnings

For external use only.

Ask a doctor before use

if condition covers larger area of body, consult your doctor before using this product.

When using this product

avoid contact wtih the eyes. If contact occurs, rinse thoroughly with water.

Stop use and ask a doctor if

condition worsens or does not improve after regular use of this product as directed, consult a doctor.

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center Immediately.

Directions

wet hair then massage liberal amount of MG217 into the scalp and leave on for several minutes. Rinse thoroughly.
for best results, use at least twice a week or as directed by a physician.

Inactive Ingredients

Purified water, Sodium laureth sulfate, Cocamidopropyl betaine, Lauryl glucoside, Sodium citrate, Coco-glucoside, Glyceryl oleate, Propanediol, Glycerin, Polyquaterinum-44, Sodium benzoate, Panthenol, Calendula officinalis flower extract, Chamomilla recutita (matricaria) flower extract, Propylene glycol, Citric acid, Chlorhexidine gluconate, Disodium EDTA

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

MG217 PSORIASIS THERAPEUTIC CONDITIONER

salicylic acid shampoo

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:68093-7242
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	0.03 g in 1 g

Ingredient Name	Strength
Inactive Ingredients
SODIUM BENZOATE (UNII: OJ245FE5EU)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
CHLORHEXIDINE GLUCONATE (UNII: MOR84MUD8E)
WATER (UNII: 059QF0KO0R)
SODIUM LAURETH SULFATE (UNII: BPV390UAP0)
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)
SODIUM CITRATE (UNII: 1Q73Q2JULR)
GLYCERIN (UNII: PDC6A3C0OX)
PANTHENOL (UNII: WV9CM0O67Z)
CALENDULA OFFICINALIS FLOWER (UNII: P0M7O4Y7YD)
MATRICARIA CHAMOMILLA FLOWERING TOP OIL (UNII: SA8AR2W4ER)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
EDETATE DISODIUM (UNII: 7FLD91C86K)
LAURYL GLUCOSIDE (UNII: 76LN7P7UCU)
COCO GLUCOSIDE (UNII: ICS790225B)
GLYCERYL OLEATE (UNII: 4PC054V79P)
PROPANEDIOL (UNII: 5965N8W85T)
POLYQUATERNIUM-44 (200000 MW) (UNII: TTD9VOM83O)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:68093-7242-1	1 in 1 CARTON	11/01/2015
1		283 g in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph final	part333D	11/01/2015

Labeler - Wisconsin Pharmacal Company (800873986)

Name	Address	ID/FEI	Business Operations
Establishment
Wisconsin Pharmacal Company		800873986	manufacture(68093-7242)

Revised: 3/2016

Document Id: 2e961928-db05-3cfd-e054-00144ff88e88

Set id: 246f239f-16fb-24b2-e054-00144ff8d46c

Version: 1

Effective Time: 20160321